BioSpace News Archive

Business

Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced a collaboration with GlaxoSmithKline plc (GSK) to use its clonoSEQ ® Assay to assess minimal residual disease (MRD) in GSK’s portfolio of hematology products. “We are thrilled to collaborate with GSK to implement our leadi

November 10, 2020
·
5 min read
Biotech Beach

Envista Announces Participation in Wolfe Research and Evercore ISI Healthcare Conferences

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 from 10:30 – 11:05 AM ET.

November 10, 2020
·
1 min read
BioMidwest

Trailhead Biosystems Raises $6.6 Million in Series A Financing

Therapeutic cell pioneer Trailhead Biosystems raises Series A funding for development of specialized human cells Financing will expand the company’s High Dimensional Design of Experiments platform (HD-DoE), support the generation of multiple specialized human cells with therapeutic properties and their pilot scale manufacturing

November 10, 2020
·
4 min read